Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology …

CC Chang, CC Blyth, SCA Chen… - Internal medicine …, 2021 - Wiley Online Library
This article introduces the fourth update of the Australian and New Zealand consensus
guidelines for the management of invasive fungal disease and use of antifungal agents in …

[HTML][HTML] Computed tomography-based radiomics improves non-invasive diagnosis of Pneumocystis jirovecii pneumonia in non-HIV patients: a retrospective study

H Yu, Z Yang, Y Wei, W Shi, M Zhu, L Liu… - BMC Pulmonary …, 2024 - Springer
Background Pneumocystis jirovecii pneumonia (PCP) could be fatal to patients without
human immunodeficiency virus (HIV) infection. Current diagnostic methods are either …

Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: a case-control study on epidemiology and risk factors on behalf of the infectious …

C Robin, C Cordonnier, G Tridello, N Knelange… - … and Cellular Therapy, 2024 - Elsevier
Pneumocystis pneumonia (PCP) is a life-threatening complication after allogeneic
hematopoietic cell transplantation (allo-HCT). However, allo-HCT procedures have evolved …

Combination of β‐(1, 3)‐D‐glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia

G Desoubeaux, A Chesnay, V Mercier… - Mycoses, 2019 - Wiley Online Library
Background Currently, the biological diagnosis of Pneumocystis jirovecii pneumonia (PjP
infection) usually relies on microbiological investigations in bronchial‐alveolar lavage fluid …

Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: implications for the diagnosis of CMV pneumonia

JL Piñana, E Giménez, MD Gómez, A Pérez… - Journal of Infection, 2019 - Elsevier
Objectives To date no definitive cut-off value for cytomegalovirus (CMV) DNA load in
bronchoalveolar lavage (BAL) fluid specimens has been established to discriminate …

[HTML][HTML] Copy Number Variation of Mitochondrial DNA Genes in Pneumocystis jirovecii According to the Fungal Load in BAL Specimens

C Valero, MJ Buitrago, M Gits-Muselli… - Frontiers in …, 2016 - frontiersin.org
Pneumocystis jirovecii is an unculturable fungus and the causative agent of Pneumocystis
pneumonia, a life-threatening opportunistic infection. Although molecular diagnosis is often …

[HTML][HTML] Usefulness of ß-d-glucan assay for the first-line diagnosis of pneumocystis pneumonia and for discriminating between pneumocystis colonization and …

J Bigot, S Vellaissamy, Y Senghor, C Hennequin… - Journal of Fungi, 2022 - mdpi.com
According to the immunodepression status, the diagnosis of Pneumocystis jirovecii
pneumonia (PjP) may be difficult. Molecular methods appear very sensitive, but they lack …

High prevalence of pneumocystis pneumonia in interstitial lung disease: a retrospective study

L Liu, T Ji, R Chen, L Fan, J Dai, Y Qiu - Infection, 2024 - Springer
Background Interstitial lung disease (ILD) is a new risk category for pneumocystis
pneumonia (PCP) with a high mortality rate. The definite diagnostic criteria of PCP in ILD …

Métodos de diagnóstico rápido de las infecciones respiratorias

JM Marimón, JM Navarro-Marí - Enfermedades Infecciosas y Microbiología …, 2017 - Elsevier
Las infecciones respiratorias agudas son la segunda causa de morbimortalidad tanto en
niños como adultos a nivel mundial en cuya etiología se implican virus, bacterias y hongos …

Use of 1, 3-β-D-glucan in invasive fungal diseases in hematology patients

DR Giacobbe, V Del Bono, C Viscoli… - Expert Review of Anti …, 2017 - Taylor & Francis
Introduction: Invasive fungal diseases (IFD) remain a leading cause of morbidity and
mortality in hematology patients. Within a diagnostic-driven approach, the use of the serum …